-
Study aim
-
The Comparison of the effectiveness of Combined medication (Pharmacotherapy and brief mindfulness-based therapy) and pharmacotherapy in improving Migraine symptoms and sleep quality in women with migraine
-
Design
-
A randomized, single blind clinical trial with a waiting group design of 28 patients, enrolled between July 2018 and October 2018
-
Settings and conduct
-
28 people were selected through available sampling method randomly and without being notified, were divided into two groups: Experiment and Waiting. For the experimental group, in addition to the conventional drug therapy, brief mindfulness-based therapy was held that lasted 2 sessions a week, for 2 weeks. But for the waiting group, only the conventional drug therapy was performed. At the end of the research, psychological intervention was also performed for the waiting group for ethical considerations
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria included receiving a diagnosis of migraine according to the psychiatrist's opinion, the age of 18-60, Level of education at least middle school and female gender. Exclusion criteria included any severe psychological disorders such as psychosis, bipolar disorder, severe depression, or personality disorders, a history of drug abuse and dependency on any particular substance, receiving any psychological treatments for migraine over the past two years and changing in drug use during the study
-
Intervention groups
-
For the waiting group, only the conventional drug therapy was performed and In the experimental group, in addition to conventional drug therapy, brief mindfulness-based therapy was performed
-
Main outcome variables
-
Migraine symptoms
Sleep quality